Key Points
- Korea's cosmetics exports reached a record $11.1 billion in the first nine months of 2026, up 31.1 percent year-on-year and nearly matching the full-year record of $11.4 billion set in 2025.
- Contract manufacturers Cosmax and Kolmar Korea — the ODMs behind many popular K-beauty brands — both reported record quarterly revenue and operating profit in Q3, driven by surging global orders.
- The two companies are pursuing different expansion paths: Kolmar is investing 173.3 billion won in a new domestic plant, while Cosmax acquired a 51 percent stake in Italy's Keminova for its first European production base.
How Korea's Behind-the-Scenes Cosmetics Makers Power the K-Beauty Boom
When a shopper in New York picks up a Korean sunscreen or a serum from a brand like Beauty of Joseon, Round Lab or Anua, the label may differ — but the factory behind it often does not. Korea's cosmetics industry is increasingly powered by original development manufacturers, or ODMs, which formulate, test and produce products for dozens of independent brands. Two names dominate this invisible layer: Cosmax and Kolmar Korea.
The scale of the boom is striking. Korea's cosmetics exports reached a record $11.1 billion in the first nine months of 2026, up 31.1 percent from a year earlier, according to the Ministry of Food and Drug Safety. That nearly matches the country's full-year record of $11.4 billion set in 2025 — with an entire quarter still to go. The United States was the largest destination at $2.35 billion, followed by China at $1.58 billion and Japan at $890 million, confirming that K-beauty has moved well beyond its traditional Asian strongholds.
The ODM model is central to this success. Rather than building their own factories and research teams, emerging brands can outsource product development and manufacturing. This lowers barriers to entry and lets small labels respond quickly to trends. The manufacturers, in turn, work with multiple brands rather than depending on any single one — a structure that has proven remarkably resilient.
The financial results reflect that momentum. Cosmax reported third-quarter consolidated revenue of 875.8 billion won ($657.5 million), up 49.5 percent year-on-year, with operating profit nearly doubling to 83.3 billion won. Kolmar Korea also set quarterly records, with revenue rising 21.3 percent to 828.2 billion won and operating profit up 40.5 percent to 81.9 billion won. Both companies are now investing to keep pace: Kolmar plans a 173.3 billion won basic-skincare plant in Sejong by 2028, while Cosmax acquired a 51 percent stake in Italy's Keminova in February, securing its first European production base with an annual capacity of about 20 million units.
At a Glance
| Main Companies | Cosmax, Kolmar Korea, Cosmecca Korea Korean ODM cosmetics manufacturers producing for third-party brands worldwide |
| Key Financial Figure | $11.1 billion Korea's cosmetics exports in the first nine months of 2026, a new record |
| Cosmax Q3 Revenue | 875.8 billion won ($657.5M) Up 49.5% year-on-year, a quarterly record |
| Kolmar Korea Q3 Revenue | 828.2 billion won Up 21.3% year-on-year, also a quarterly record |
| Key Transaction | 51% stake in Keminova (Italy) Cosmax's acquisition of an Italian manufacturer, securing its first European production base |
| Key Investment | 173.3 billion won Kolmar Korea's planned new basic-skincare facility in Sejong, targeted for 2028 completion |
| Key Term | ODM (Original Development Manufacturer) Companies that develop formulas and manufacture products for client brands, lowering barriers to entry |
| Top Export Markets | US ($2.35B), China ($1.58B), Japan ($890M) Largest destinations for Korean cosmetics exports in the first nine months of 2026 |
| Key Forecast | $17.8 billion (2027 exports) NH Investment & Securities projection for next year, with 2026 estimated at $14.5 billion |
Cosmax vs. Kolmar Korea: Two ODM Strategies, One Global Race
Why the ODM Model Is K-Beauty's Real Competitive Edge
The defining feature of Korea's cosmetics export surge is not a single blockbuster brand but an industrial ecosystem. ODMs like Cosmax and Kolmar Korea do far more than fill bottles: they develop formulations, select ingredients and manage the entire journey from concept to shelf-ready product. This allows independent labels — Beauty of Joseon, Round Lab, Anua, Medicube — to compete globally without owning factories or large research teams. For context, this mirrors the contract-manufacturing model that transformed industries from semiconductors to pharmaceuticals, where specialized producers capture value regardless of which end brand wins.
Cosmax vs. Kolmar Korea: Diverging Expansion Strategies
Both companies are growing, but their approaches to capacity differ. Kolmar Korea is doubling down on domestic production with a 173.3 billion won facility in Sejong, betting on Korea's established network of ingredient suppliers, packaging firms and research talent. Cosmax is going global, acquiring a 51 percent stake in Italy's Keminova to establish a European manufacturing foothold. The logic is straightforward: local production shortens delivery times, cuts logistics costs and helps attract overseas brands that want regionally produced goods. Cosmax's US subsidiary already showed the payoff, with third-quarter revenue up 88.2 percent to 69.5 billion won and a second consecutive quarter of operating profit.
The Pressure Points: Cosmecca and Kolmar's US Struggles
Not every ODM is benefiting equally. Cosmecca Korea reported 35.7 percent revenue growth to 247.5 billion won, but operating profit edged up just 0.1 percent to 27.2 billion won. The company cited higher outsourcing costs for filling and packaging as demand outpaced its internal capacity — a classic bottleneck when orders surge faster than production lines can be built. Kolmar Korea faces a different problem in North America: its US and Canadian plants operated at just 8.1 percent and 17.6 percent of capacity respectively in the third quarter. Despite US revenue more than doubling to 18 billion won, the overseas business posted an operating loss of 3.8 billion won. Low utilization suggests the company expanded capacity ahead of demand, or that local customer acquisition is proving slower than expected.
What NH Investment & Securities Expects Next
NH Investment & Securities projects Korean cosmetics exports will reach $17.8 billion in 2027, with 2026 estimated at $14.5 billion — a 32 percent increase over 2025. The brokerage highlighted Europe as particularly encouraging, with exports to the region surpassing North America for the first time. It also pointed to growing demand in emerging markets such as the Middle East and Latin America. If those forecasts hold, ODM order books will remain full, but the Cosmecca case shows that margin pressure — not demand — is the sector's key risk. Both Cosmax and Kolmar are now turning to AI to improve formulation research, ingredient safety prediction, color matching and personalized beauty solutions, aiming to strengthen technological capabilities as competition intensifies.
What the K-Beauty ODM Surge Means for Brands, Investors and Suppliers
The K-beauty boom is real, but the winners are not evenly distributed — manufacturing capacity, not brand appeal, is the binding constraint right now.
For investors and executives watching Korea's cosmetics supply chain, the Q3 results reveal a clear split. Cosmax and Kolmar Korea are capturing the bulk of the upside, while Cosmecca's near-flat operating profit despite 35.7 percent revenue growth shows what happens when demand outruns production capacity and outsourcing costs eat into margins.
- Watch Kolmar Korea's US plant utilization. At 8.1 percent (US) and 17.6 percent (Canada) in Q3, these facilities are far below breakeven. Any improvement in utilization rates — or further deterioration — will be a key signal of whether the North American expansion strategy is working.
- Track Cosmax's European ramp-up. The Keminova acquisition gives Cosmax 20 million units of annual European capacity. How quickly that facility reaches full utilization will determine whether the company's overseas strategy delivers returns or becomes a drag.
- Monitor Cosmecca's margin recovery. The company's 0.1 percent operating profit growth despite strong revenue suggests structural pressure. If outsourcing costs remain elevated, Cosmecca may need to invest in its own capacity — a capital-intensive move that could strain its balance sheet.
- Watch for NH Investment & Securities' export forecast to materialize. The brokerage projects $17.8 billion in Korean cosmetics exports for 2027. If monthly export data from the Ministry of Food and Drug Safety tracks below that trajectory, expect ODM order books to soften.
Risk & Opportunity Assessment
| Commercial Risk | Medium | Cosmecca Korea's operating profit grew just 0.1 percent despite 35.7 percent revenue growth, showing that surging demand can pressure margins when production capacity is insufficient. Kolmar Korea's US operations posted a 3.8 billion won operating loss. |
| Competitive Risk | Medium | The ODM model has low barriers to entry for brands, but competition among manufacturers is intensifying. Cosmax and Kolmar Korea are investing heavily in capacity and AI capabilities, which could squeeze smaller players like Cosmecca. |
| Regulatory Risk | Low | The article does not identify specific regulatory threats. However, overseas operations bring additional regulatory requirements, as noted by an ODM industry official, particularly in the US and Europe. |
| Reputation Risk | Low | The article presents the ODM model as a strength of K-beauty, not a controversy. No reputational issues are raised for any named company. |
| Technology Disruption | Medium | Both Cosmax and Kolmar Korea are adopting AI for formulation optimization, ingredient safety prediction, color matching and personalized beauty. Companies that lag in AI adoption could lose competitive edge. |
| Commercial Opportunity | High | NH Investment & Securities projects Korean cosmetics exports will reach $17.8 billion in 2027, up from an estimated $14.5 billion in 2026. Europe surpassed North America for the first time, and emerging markets like the Middle East and Latin America are expanding. |
Comments 0